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We have examined cell-free viral populations in the blood plasma and seminal plasma compartments of men
infected with subtype C human immunodeficiency virus type 1 (HIV-1) using the V3-specific heteroduplex
tracking assay (V3-HTA). We studied two cohorts of subjects who had visited either a sexually transmitted
disease (STD) clinic for genital tract inflammation in the form of urethritis (n 5 43) or a dermatology clinic
(controls, n 5 14) in Malawi. We have previously shown that the presence of urethritis is associated with an
eightfold increase in virus load in the seminal plasma compartment (M. S. Cohen et al., Lancet 349:1868–1873,
1997). The purpose of this study was to determine whether genital tract inflammation and its treatment caused
genetic instability in cell-free HIV-1 populations. In a cross-sectional analysis at study entry, three-fourths of
the STD and control subjects had multiple V3 populations in their blood while 60% of the STD subjects and
79% of the control subjects had multiple V3 populations in their semen. Overall, one-fourth of all of the
subjects showed discordance between results with blood and semen specimens when samples were compared
for the presence and absence of subpopulations. When differences in the relative levels of abundance of bands
were also taken into account, two-fifths of all of the subjects showed discordance between the compartments.
Among the subset of subjects in whom multiple virus populations could be detected, half showed discordance
between the compartments. There were no differences between STD and control cohorts for these comparisons
of the compartments in this cross-sectional analysis at study entry. Longitudinal analysis of the viral popu-
lations from two separate clinic visits over 1 to 4 weeks showed that the complexity of each V3 population as
measured by Shannon entropy was different in blood and semen at the two time points, indicating that the
blood and semen constitute different compartments for HIV-1. The seminal plasma compartment was more
dynamic than the blood plasma compartment for the STD subjects who were treated for urethritis, with
changes being noted in the presence or absence of V3-HTA bands in the semen of 29% of these subjects but in
the blood of only 9% of these subjects. However, the changes were generally small. Overall, our results suggest
that 40% of male subjects show discordance between seminal and blood viral populations and that the
complexity of each V3 population was different between the two compartments. Both of these results point to
the partial independence of the seminal compartment as a viral niche within the body.
Human immunodeficiency virus type 1 (HIV-1) is primarily
transmitted by sexual intercourse (23). The efficiency of trans-
mission of HIV-1 is likely to depend on the concentration of
HIV-1 in genital secretions; increased heterosexual transmis-
sion has been associated with higher viral loads in blood (17,
21, 22). The genotypic and phenotypic characteristics of HIV-1
are also important for efficient transmission (12, 13, 31). The
male genital tract represents a unique compartment, since
mutations conferring resistance to antiviral drugs, changes in
the viral envelope, and/or other characteristics can differ in
HIV-1 sequences recovered from blood and semen (5, 7, 8, 11,
28, 32). The amount of HIV-1 (cell free and cell associated) in
semen can vary widely between different men (4, 7, 25) and can
vary over time in each man (16). While high HIV-1 levels in
semen are correlated with advanced HIV-1 disease, the virus
has been detected and/or cultured from semen collected dur-
ing all phases of infection (1, 25, 26, 30).
Classical sexually transmitted infections that cause genital
ulcers or mucosal inflammation facilitate transmission of
HIV-1 by increasing the infectiousness of the index case, the
susceptibility of the exposed sexual partner, or both (14). We
have shown that men with urethritis have higher HIV-1 levels
in their semen than does a control population and that appro-
priate antibacterial therapy reduces HIV-1 concentration in
semen (6).
We have previously used a V3-specific heteroduplex tracking
assay (V3-HTA) to examine populations of HIV-1 variants in
blood plasma (18, 20). In the present study we used this assay
to compare populations of HIV-1 in the cell-free plasma frac-
tions of blood and semen in different patient cohorts over time
and before and after antibacterial therapy for urethritis. We
focused on the virus from cell-free plasma from blood and
semen since cell-free virion pools contain the actively replicat-
ing virus and, in one documented case, the cell-free virus from
semen from a transmitter contained the same variant as was in
the recipient (32). We were particularly interested in deter-
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mining the relationship between HIV-1 variants in blood and
semen because of previous work showing differences between
the peripheral blood and seminal cell compartments in men
with subtype B HIV-1 (8). In addition, our clinical study (6)
provided samples appropriate for evaluating the effect(s) of
local inflammation caused by urethritis on populations of
HIV-1 in semen and blood.
MATERIALS AND METHODS
Source of patient samples. A subset of the cohort of HIV-1-infected men from
Malawi originally described by Cohen et al. (6) was chosen for this study. Blood
and semen were collected at 1- and 2-week intervals from two groups of men
seen either at a sexually transmitted disease (STD) clinic or (as controls) at a
dermatology clinic in Lilongwe, Malawi. A subset was chosen because reverse
transcription (RT)-PCR products for V3-HTA could be obtained from matched
blood and semen samples collected on the initial visits of the subjects to either
the STD clinic or the dermatology clinic. Men from this subset were then
selected for a second subset if RT-PCR products for V3-HTA could be obtained
from a second set of matched blood and semen samples collected at a subsequent
visit to one of the clinics. All participants in the study were given physical exams
and were tested for STDs (6). Subjects were determined to have urethritis if
discharge was found during the physical examination and there were at least five
white blood cells per high-power field on a Gram-stained urethral smear. All of
the STD subjects and none of the controls in the present analysis had urethritis.
Two of the control subjects had syphilis, and three had asymptomatic trichomo-
nas and were included because they did not have urethritis. All subjects with
STDs were treated with appropriate antibiotics, and controls who did not have an
STD were not treated with any antibiotics.
Viral RNA isolation, RT-PCR, and V3-HTA. Cell-free plasma from blood and
semen were separated as described previously (6) and stored frozen. Viral RNA
was extracted from the blood plasma and seminal plasma using a QIAamp viral
RNA extraction kit (Qiagen, Valencia, Calif.). RT-PCR was performed as de-
scribed previously (20), with each RT-PCR being repeated at least once to verify
representative sampling of the RNA templates. V3-HTA was performed with the
subtype C probe as described previously (20). The consensus subtype B probe
was constructed by amplifying the same 159-bp V3 sequence as that used for the
subtype C probe from a JR-FL molecular subclone (pUC112-1 from Irvin Chen,
University of California, Los Angeles [15]) by using the C1V3 and C2V3
primers (20). The PCR product was cloned using a pT7Blue Perfectly Blunt
cloning kit (Novagen, Madison, Wis.). The subtype B probe was labeled by first
digesting the plasmid with NheI, end-labeling one strand by a fill-in reaction of
the NheI overhangs with a-35S-dATP and the Klenow fragment of DNA poly-
merase I (New England Biolabs, Beverly, Mass.), and then inactivating the
Klenow fragment and digesting with KpnI. The labeled probe was then purified
away from the unincorporated nucleotides using a MicroSpin G-50 column
(Amersham Pharmacia, Arlington Heights, Ill.). V3-HTA with the subtype B
probe was otherwise performed in the same manner as with the subtype C probe.
For subjects with four samples (two blood plasma and two seminal plasma
samples), multiple V3-HTA bands first were scored for the presence or absence
of bands between samples. The relative abundance of each band within a sample
was then visually estimated for each subject to generate a data set for statistical
analysis.
Statistical methods. We used Fisher’s exact test for hypotheses of indepen-
dence between two factors with two levels when tables contained cells with
results from fewer than five observations, and we used the chi-square test oth-
erwise. To compare two groups with more than two levels, we used the Mantel-
Haenszel test. We used the Wilcoxon rank sum test to compare medians between
the STD and control groups and used the Student paired t test to examine
subject-specific differences. To study the frequency distribution of bands in a





where p(i) is the relative frequency of band i (i 5 1,. . .n, where n is the total
number of bands) (24). This quantity measures the amount of uncertainty in the
distribution and was used in a similar manner by Delwart et al. (9). It is 0 when
there is a single band (i.e., n 5 1) and reaches its maximum value when the
observed bands are equally frequent [i.e., p(i) 5 1/n for all i]. We monitored the
changes in the distribution of bands in an individual via determining the entropy
and looked for changes in this value. To relate the changes in RNA values to
changes in the entropy, we fitted a generalized-estimating-equation model with
an unstructured covariance matrix (for visits 1 and 2 in both STD and control
groups) using PROC GENMOD in SAS version 7.0 (SAS Institute, Inc., Cary,
N.C.).
RESULTS
The STD and control groups are well matched. We have
used a collection of samples previously obtained (6) to examine
the effects of STDs on cell-free HIV-1 populations in blood
and seminal plasma. Paired blood and semen samples had
been collected during initial clinic visits by 43 HIV-1-infected
men with urethritis from an STD clinic cohort (Table 1) and 14
HIV-1-infected men from a dermatology clinic (control) co-
hort (Table 2). Age, CD41 T-cell counts, and viral loads in
blood were similar in STD and control subjects. Median ages
were 28 years for the STD group and 29 years for the control
group, respectively (P 5 0.94). Median CD41-T-cell counts
were 259/ml for the STD subjects and 268/ml for the control
TABLE 1. HIV-1 viral loads in blood and semen, the number of
days between the two clinic visits, CD41 T-cell counts,
diagnosed STDs, and ages for the 43 subjects
enrolled at the STD clinic
Subject








Visit 1 Visit 2 Visit 1 Visit 2
S008 83 150 160 72 11 NDd Gon, Tri 21
S017 610 380 25 6.2 13 178 NPI 28
S018 390 250 50 91 12 476 Gon, Tri, Ulc 42
S021 47 21 56 190 13 154 Gon 25
S029 170 170 51 26.4 21 496 Gon 35
S031 90 43 42 84 7 333 Gon, Ulc 39
S036 28 87 110 2.8 11 631 Gon 38
S047 590 920 84 37 19 469 Gon 27
S053 1,300 760 1,200 240 14 318 Tri, Ulc 27
S059 920 1,300 4,100 890 7 259 Gon 28
S067 80 59 110 5.2 14 ND Gon 23
S073 39 32 40 17 8 275 Gon 35
S075 390 800 160 12 14 ND NPI 27
S081 79 130 1,900 610 13 101 Gon 23
S083 ND ND 3,600 318 8 166 Gon, Tri, Ulc 29
S088 33 130 1,500 1,000 7 569 Gon 34
S094 210 ND 340 22 14 101 Tri, Ulc 25
S099 370 160 660 270 14 ND Gon, Tri 26
S100 160 150 3,900 1,600 14 210 Gon 27
S102 7.3 3.7 130 70 28 ND NPI 29
S128 110 36 130 74 14 ND Gon 30
S134 390 580 290 1 15 534 Gon 35
S137 480 750 110 160 15 69 Gon 44
S139 37 130 240 940 14 ND Gon 26
S141 9.7 6.9 140 74 14 115 Gon 28
S148 120 66 960 1,200 7 344 Gon 40
S159 750 430 960 290 7 98 Tri 26
S171 260 180 190 71 8 441 Tri, Ulc 21
S172 63 19 150 42 14 344 Gon 24
S180 170 230 1,500 450 9 37 Gon, Tri, Ulc 31
S191 1,200 800 235 18 11 187 Ulc 50
S199 430 260 340 130 9 184 Tri, Ulc 27
S200 2,200 5,700 55 700 6 132 Ulc 25
S206 420 540 860 2,400 7 168 Gon, Ulc 36
S007 130 18 273 NPI 34
S019 15 300 712 Gon 26
S084 ND 260 248 Gon, Ulc 27
S101 670 770 235 Gon, Chl 32
S103 8.9 100 454 Gon 41
S107 120 5.6 806 NPI 24
S111 200 79 ND Gon 50
S173 15 180 36 Gon 29
S194 67 1,500 322 Gon 22
a Times 103 copies per milliliter of HIV-1 RNA.
b CD41 T cells per microliter.
c Diagnosed STD. Gon, gonorrhea; Tri, trichomonas; Ulc, genital ulcers; Chl,
chlamydia; NPI, no pathogen identified.
d ND, not determined.
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subjects (P 5 0.73). Median viral loads in blood plasma were
1.6 3 105 and 3.4 3 105 copies/ml for the STD and control
groups, respectively (P 5 0.52). The median viral load in sem-
inal plasma was higher in subjects with urethritis (1.8 3 105
copies/ml) than in control subjects (6.2 3 104 copies/ml), but
the difference was not statistically significant (P 5 0.31). Men
in the larger STD cohort from the original study (n 5 86) had
significantly higher viral loads in semen than did men in the
original control cohort (n 5 49) (6); however, only subjects
from whom V3 sequences could be reproducibly amplified
from both blood and semen were studied here.
Gonorrhea was the most common cause of urethritis, being
present in a majority of the members of the small STD cohort
studied (Table 1); 10 subjects had trichomonas, 1 subject had
chlamydia, and 6 subjects had more than one pathogen. Twelve
subjects also had a genital ulcer, which we have previously
shown is correlated with increased excretion of HIV-1 in se-
men (10). Two of the control subjects had syphilis and three
had asymptomatic trichomonas, but none of these five subjects
had urethritis.
Blood and seminal plasma samples from a second clinic visit
by 34 of the STD subjects and 12 of the control subjects were
also examined (Tables 1 and 2). The subjects seen at the STD
clinic were treated for their STDs with antibiotics, so that the
inflammation had cleared in most of the men by the second
clinic visit. None of the subjects were under treatment with
antiretroviral therapy. The median changes in blood plasma
viral loads between the two visits were decreases of 3.6 3 103
copies/ml for the STD group and 2.3 3 104 copies/ml for the
control group; neither of these median changes was statistically
significant (P 5 0.78, P 5 0.66), and the medians were not
significantly different from one another (P 5 0.67). The me-
dian change in seminal plasma viral load for the control group
was an increase of 2.5 3 104 copies/ml, which was also not
statistically significant (P 5 0.47). For the STD group, the
median change in seminal plasma viral load after therapy was
a decrease of 1.0 3 105 copies/ml, which was statistically sig-
nificant (P 5 0.04) and was significantly different from the
median change in the control group (P 5 0.003).
Cross-sectional comparison of the blood and seminal com-
partments at the first visit. HIV-1 populations in the cell-free
fractions of blood and semen samples from the first clinic visit
were analyzed using V3-HTA, and the patterns were scored for
the presence of multiple bands, with each band representing a
distinct genotype. All of the samples were first analyzed using
a subtype C probe. However, because many of the subjects had
only a single V3 population that was detected with the subtype
C probe, we also used a subtype B probe for V3-HTA that was
more sensitive to minor differences among subtype C se-
quences because of the clusters of mismatches between the
subtype B probe and the subtype C sequences (Fig. 1A). By
using both probes, a larger number of V3 variants could be
identified. V3-HTA with the subtype B probe was done only on
the RT-PCR products from those subjects for whom only sin-
gle bands were seen in both the blood plasma and seminal
plasma compartments using the subtype C probe. Figure 1B
shows the V3-HTA results with the subtype B and subtype C
probes on the same samples from two representative subjects.
For both of these subjects, single bands with the subtype C
probe were resolved as multiple bands using the subtype B
probe. Overall, 31 of the 43 STD subjects (72%) and 10 of the
14 controls (71%) had multiple populations in their blood.
Similar results were obtained for the seminal compartment
with the two cohorts; 26 STD subjects (60%) and 11 control
subjects (79%) had multiple genotypic populations in their
semen (P 5 0.22).
The V3-HTA patterns in the blood and seminal compart-
ments of each subject were next compared for differences in
the number of bands. V3-HTA results illustrating examples of
the V3 population patterns are shown in Fig. 2. Subjects S159
and C011 had the same V3-HTA pattern in their blood and
semen (Fig. 2A). In contrast, subject S171 had two V3 popu-
lations in his blood but only one of them was detected in his
semen, while subject C047 had two V3 populations in his
semen and only one was detected in his blood (Fig. 2B). In all
cases, the test was reproduced at least once with each sample
to document sufficient template sampling to justify the com-
parisons.
The results of the compartment comparisons are shown in
Table 3. Nearly every subject (in both the STD and control
groups) with a single viral population in his blood had that
same population in his semen. In the STD and control subjects
with multiple viral populations in their blood, most had the
same populations in their semen. Overall, less than one-fourth
of the subjects showed differences between the two compart-
ments. The STD and control groups had similar percentages of
subjects in each category in Table 3 (P 5 0.78), indicating that
the higher HIV-1 RNA load in the semen of men with an STD
did not change the likelihood that their seminal virus would be
different from the virus in blood, at least as assessed by a
determination of discrete V3 populations.
As a more sensitive measure of the similarity or difference
between the blood and seminal compartments, we rescored the
V3-HTA patterns for the subjects with multiple bands in their
blood for differences in the relative levels of abundance of the
populations. Examples of V3-HTA patterns showing this type
of difference are shown in Fig. 2C. More subjects showed
differences between the compartments by this analysis, with
half of the subjects with multiple V3 populations having dif-
ferent V3-HTA patterns between blood and semen (16 of 31
STD subjects and 5 of 10 control subjects), and again there was
no difference between the STD and control subjects (P 5
0.75). When relative-abundance differences are taken into ac-
count, two-fifths of all of the subjects showed discordance
between the compartments.
TABLE 2. HIV-1 viral loads in blood and semen, the number of
days between the two clinic visits, CD41 T cell counts, and ages
for the 14 control subjects enrolled at the dermatology clinic
Subject








Visit 1 Visit 2 Visit 1 Visit 2
C010d 43 6.5 6,700 13 17 NDc 26
C011d 540 270 11 26 14 67 28
C012 380 270 2,500 5,600 14 863 48
C018 490 1,600 1,300 2,300 14 116 28
C030 580 2,300 10.8 45 14 322 31
C034 3,500 3,300 38 250 14 268 23
C047 140 130 860 210 14 291 40
C059d 5.2 4.6 1 40 15 465 25
C061 360 160 3,200 4,400 14 262 25
C071 320 680 68 13 14 ND 45
C124 54 47 7.3 8.7 10 ND 25
C128d 220 120 56 23 6 159 30
C111 69 890 210 31
C113d 360 38 279 30
a Times 103 copies per milliliter of HIV-1 RNA.
b CD41 T cells per microliter.
c ND, not determined.
d Subjects C010 and C011 had syphilis without urethritis; subjects C059, C128,
and C113 had asymptomatic trichomonas without urethritis.
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Temporal changes in virus populations in blood and semen.
Blood and seminal plasma samples from two separate clinic
visits were analyzed by V3-HTA for 34 STD and 12 control
subjects. The median time between visits was 13 days for the
STD group and 14 days for the control group. Examples of the
V3-HTA patterns seen in the comparison of the two sets of
blood and semen samples are shown in Fig. 3. Subject S094 had
the same pattern in all four samples, while subject S029 had the
FIG. 1. (A) Comparison of the probes used for V3-HTA. The subtype C probe was cloned from subject C128 as described previously (20), while the subtype B probe
was derived from the JR-FL molecular clone (15). (B) Examples of V3-HTA patterns for two subjects that showed different numbers of bands with the subtype C and
subtype B probes. Only the bottom portions of the gels are shown. The arrow indicates the position of the probe homoduplex. Lanes are labeled by sample type at the
first visit (blood [1B] or semen [1S]).
FIG. 2. Examples of the V3-HTA patterns of subjects with the same bands in blood and semen (A), subjects with different bands in blood and semen (B), and
subjects with different relative levels of abundance of the same bands in blood and semen (C). The lanes are labeled as in Fig. 1, and the arrow indicates the position
of the probe homoduplex. The V3-HTA patterns with the subtype C probe are shown for subjects S099 and C034; the V3-HTA patterns with the subtype B probe are
shown for the other four subjects.
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same pattern in his blood over time but a change in his seminal
pattern over time. Subject S036 had the same pattern in his
blood and semen at both visits, but the pattern changed over
time.
The V3-HTA patterns were scored for each of the four
samples from the 46 subjects first for changes in which bands
were present and then for changes in the relative abundance of
each band. Changes in the blood and the seminal compart-
ments were analyzed in parallel for each subject for both anal-
yses (Table 4). When only the presence or absence of specific
bands was taken into account, the virus populations were stable
in both compartments, since only one control subject (8%)
showed changes in the seminal plasma and none showed
changes in the blood plasma. For the STD subjects, the seminal
compartment was more dynamic while their genital inflamma-
tion was being treated because 10 of the STD subjects (29%)
showed changes in their semen but only three of these subjects
(9%) showed changes in their blood (P 5 0.02).
In the second analysis in which the relative abundance of
each band was also considered, similar results were obtained
(Table 4). For the control group, three subjects (25%) showed
changes in the viral populations in their blood and three other
subjects showed changes in their semen, which were not sta-
tistically different between the compartments (P 5 0.51). In the
STD group, 3 subjects (9%) showed changes in their blood
while a total of 15 subjects (44%) showed changes in their
semen, although in this case the difference between the com-
partments did not reach statistical significance (P 5 0.08). It
should be noted that the subjects included in these groups were
selected based on our ability to reproducibly amplify the V3
regions from all four samples. The ability to amplify the V3
region from extracted RNA tended to correlate with higher
viral loads; thus, this subset of subjects is, by necessity, a biased
sampling of the original cohort (6).
The complexity of the V3 populations in both the numbers
of bands and abundance of each band was calculated as the
Shannon entropy. This entropy was calculated for the four
samples from each subject. Statistical modeling was done using
the entropy values and the viral loads (at the first visit) from
each compartment for the STD and control subjects together.
Higher viral loads in the blood at the first visit were significant
predictors of higher V3 complexity at both visits (P , 0.0001),
but the seminal viral loads at the first visit were not predictive
(P 5 0.57). The complexity of the V3 populations in the blood
plasma was different from that in the seminal plasma at each
time point (first blood sample versus first semen sample and
second blood sample versus second semen sample) and across
time points (first blood sample versus second semen sample
and second blood sample versus first semen sample), indicating
that these are separate compartments for HIV-1 (P 5 0.01 for
all comparisons). The complexity of each V3 population was
the same, however, between the two visits within each com-
partment (P 5 0.65 for blood plasma and P 5 0.95 for seminal
plasma). All of these comparisons held true for the STD group
alone, but the control group sample size was too small for
reliable parameter estimation.
In only one of the analyses of these data was there a statis-
tically significant difference in the frequency of changes be-
tween the two compartments, which was for the STD group
when changes were scored by the presence or absence of
bands. When relative abundance was included, the differences
between changes in the blood and changes in the semen were
no longer statistically significant; also, when the magnitude of
the differences was included in the entropy calculation, the
compartments were the same. Therefore, there are differences
TABLE 3. Comparison of the bands in blood and seminal
compartments at the first visit
Subjects (n)

















With STD (43) 11 (26) 1 (2) 22 (51) 9 (21)
Control (14) 3 (21) 1 (7) 8 (57) 2 (14)
FIG. 3. Examples of V3-HTA patterns for subjects from whom specimens were collected at two time points for each compartment. Lanes are labeled by visit number
(1 or 2) as well as sample type (blood [B] or semen [S]). The subtype C probe was used for subject S094, and the subtype B probe was used for subjects S029 and S036.
The arrow indicates the position of the probe homoduplex.
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between the seminal samples and the blood samples at each
time point, but the differences are small.
DISCUSSION
We examined the V3 populations in the cell-free fractions of
matched blood and semen specimens collected from men who
were concomitantly infected with HIV-1 and one or more STD
pathogens causing urethritis. Virions in the cell-free fractions
of both blood and semen were studied because they represent
the viral variants being produced at the time of sample collec-
tion. At the initial visit, multiple V3 populations were present
in the blood and semen from both the STD subjects and a
control population. About two-fifths of all of the subjects had
detectable differences in viral populations between the blood
and semen and the complexity of each V3 population was
significantly different between the compartments, as might be
predicted based on earlier work (5, 7, 8, 11, 28, 32). There were
no differences in these analyses between the STD and control
groups at the initial visit, indicating that the presence of ure-
thritis did not result in an increased likelihood of having mul-
tiple V3 populations and did not change the relationship be-
tween the blood and seminal compartments.
We also compared the blood and seminal compartments
over time. Our results demonstrated that HIV-1 populations in
blood remained largely stable over the full 28 days of the study.
However, the viral populations in semen specimens from 29%
of the treated STD subjects showed changes in the presence or
absence of V3-HTA bands over this time, although the changes
were generally small and this difference in the frequency of
changes in the two compartments was not significant when it
was calculated using values for the relative abundance of the
bands or entropy measures. This observation suggests that
HIV-1 populations in the seminal compartment are more dy-
namic than in the blood compartment, specifically while the
viral load is decreasing during treatment and resolution of
genital inflammation.
Inflammation of the genital tract caused by sexually trans-
mitted diseases causes a significant increase in excretion of
HIV-1 (reviewed in reference 29) and likely facilitates trans-
mission of HIV-1 (21). However, it is not clear whether the
increase in viral burden in the genital tract results from HIV-1
replication in cells already present in the genital tract, HIV-1-
infected cells from blood directed to the genital tract by in-
flammatory cytokines and chemokines (2), transudation of cell-
free virus from the blood plasma to the seminal plasma, or
combinations of the above. However, increased recovery of
HIV-1 in semen has been associated with increased numbers of
leukocytes in semen (1).
These results do not allow final conclusions about the source
of HIV-1 in semen. However, if the influx of cell-free HIV-1 or
HIV-1-infected cells from blood was primarily responsible for
the increased level of HIV-1 in semen from men with urethri-
tis, we would expect a stronger relationship between HIV-1 in
blood and semen from the STD subjects at the initial visit. The
continued change in HIV-1 in semen after appropriate anti-
bacterial therapy supports the idea of local genital tract HIV-1
replication, likely in response to continued exposure of HIV-1
to key inflammatory cytokines (2, 25).
We examined the viral populations in these compartments
using V3-HTA in order to understand better the relationship
between HIV-1 in blood and semen. We adapted the V3-HTA
to detect viral populations based on other features of V3 se-
quence variability because subtype C HIV-1, unlike other sub-
types, tends to remain R5 throughout the disease (3, 19, 20,
27). By using a probe for V3-HTA from a different subtype as
well as the homologous subtype C probe, we were able to
increase the sensitivity of the assay for other features of genetic
variation (Fig. 1).
Limitations of this study should be emphasized. First, while
V3-HTA can identify subpopulations of HIV-1, such popula-
tions must represent at least 3 to 5% of the whole (W. Resch,
N. Parkin, E. L. Stuelke, and R. Swanstrom, submitted for
publication), and this method of population characterization
was restricted to the small region encoding V3. Therefore, we
would not be able to detect variations in minor subpopulations
or subpopulations defined by variability in other regions of the
viral genome. Second, our questions would be best served if we
were able to study subjects before, during, and after urethral
inflammation. However, we were able to examine each sub-
ject’s HIV-1 populations only at the time of inflammation and
briefly thereafter. Our conclusions about the effect of genital
inflammation on the relationship between the blood and sem-
inal compartments were drawn from cross-sectional compari-
sons of the STD and control cohorts. Third, our study cohorts
were small subgroups of the original cohorts and were biased
toward higher viral loads in both compartments, since higher
RNA levels are generally correlated with better template sam-
pling during PCR amplification. Finally, antibiotic treatment
was a variable in this study, since most of the control subjects
did not receive antibiotics and each subject who was treated
was given different antibiotics appropriate for his infection.
These limitations notwithstanding, the results of this study
offer further insight into issues critical to our understanding of
the transmission and the prevention of transmission of HIV-1
from men to their partners. Reduction of viral burden in the
semen of men with STDs is not likely to reduce heterogeneity
in viral populations. In addition, biological interventions to
prevent sexual transmission of HIV-1 from men to their part-
ners, whether through vaccines, antiretroviral agents, or other
means, must include an examination of HIV-1 in the genital
tract, from which the virus is sexually transmitted. Populations
of HIV-1 in blood cannot be expected to represent fully the
populations in the semen, especially since HIV-1 populations
in semen can change without similar changes occurring in
blood.
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